Lyciumin BCAS# 125756-66-3 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 125756-66-3 | SDF | Download SDF |
PubChem ID | 14430292.0 | Appearance | Powder |
Formula | C44H52N10O11 | M.Wt | 896.96 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 11-(hydroxymethyl)-2-[[3-(1H-indol-3-yl)-2-[[1-(5-oxopyrrolidine-2-carbonyl)pyrrolidine-2-carbonyl]amino]propanoyl]amino]-3,6,9,12-tetraoxo-5-propan-2-yl-1,4,7,10,13-pentazatricyclo[14.6.1.017,22]tricosa-16(23),17,19,21-tetraene-14-carboxylic acid | ||
SMILES | CC(C)C1C(=O)NCC(=O)NC(C(=O)NC(CC2=CN(C(C(=O)N1)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C5CCCN5C(=O)C6CCC(=O)N6)C7=CC=CC=C27)C(=O)O)CO | ||
Standard InChIKey | BWRVBFMWWHWLBW-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C44H52N10O11/c1-22(2)36-41(61)46-19-35(57)48-31(21-55)39(59)50-30(44(64)65)17-24-20-54(32-11-6-4-9-26(24)32)37(42(62)51-36)52-38(58)29(16-23-18-45-27-10-5-3-8-25(23)27)49-40(60)33-12-7-15-53(33)43(63)28-13-14-34(56)47-28/h3-6,8-11,18,20,22,28-31,33,36-37,45,55H,7,12-17,19,21H2,1-2H3,(H,46,61)(H,47,56)(H,48,57)(H,49,60)(H,50,59)(H,51,62)(H,52,58)(H,64,65) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Lyciumin B Dilution Calculator
Lyciumin B Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.1149 mL | 5.5744 mL | 11.1488 mL | 22.2975 mL | 27.8719 mL |
5 mM | 0.223 mL | 1.1149 mL | 2.2298 mL | 4.4595 mL | 5.5744 mL |
10 mM | 0.1115 mL | 0.5574 mL | 1.1149 mL | 2.2298 mL | 2.7872 mL |
50 mM | 0.0223 mL | 0.1115 mL | 0.223 mL | 0.446 mL | 0.5574 mL |
100 mM | 0.0111 mL | 0.0557 mL | 0.1115 mL | 0.223 mL | 0.2787 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Theasaponin E1
Catalog No.:BCX1302
CAS No.:220114-28-3
- Kakkanin
Catalog No.:BCX1301
CAS No.:63770-91-2
- 16α-hydroxy-3-oxo-lanosta-7,9(11),24-trien-21-oic acid
Catalog No.:BCX1300
CAS No.:862109-64-6
- Xylopine
Catalog No.:BCX1299
CAS No.:517-71-5
- Lyciumin A
Catalog No.:BCX1298
CAS No.:125708-06-7
- Kanshone C
Catalog No.:BCX1297
CAS No.:117634-64-7
- Hypoglaunine D
Catalog No.:BCX1296
CAS No.:220751-00-8
- Amaroswerin
Catalog No.:BCX1295
CAS No.:21233-18-1
- t-OMe-Byakangelicin
Catalog No.:BCX1294
CAS No.:79638-04-3
- Ajugasterone C 2-acetate
Catalog No.:BCX1293
CAS No.:154510-93-7
- Chaparrinone
Catalog No.:BCX1292
CAS No.:22611-34-3
- Physcion-8-O-β-gentiobioside
Catalog No.:BCX1291
CAS No.:84268-38-2
- Poststerone
Catalog No.:BCX1304
CAS No.:10162-99-9
- Corymbiferin
Catalog No.:BCX1305
CAS No.:5042-09-1
- Shinjulactone M
Catalog No.:BCX1306
CAS No.:103630-27-9
- 13α,21-Dihydroeurycomanone
Catalog No.:BCX1307
CAS No.:129587-06-0
- Entadamide A
Catalog No.:BCX1308
CAS No.:100477-88-1
- 3'-O-Angeloylhamaudol
Catalog No.:BCX1309
CAS No.:84272-84-4
- Theasaponin E2
Catalog No.:BCX1310
CAS No.:220114-30-7
- Oxypeucedanin hydrate-3”-ethyl ether
Catalog No.:BCX1311
CAS No.:55481-87-3
- Isooxypeucedanin
Catalog No.:BCX1312
CAS No.:5058-15-1
- Poricoic acid BM
Catalog No.:BCX1313
CAS No.:1815623-74-5
- Neoartanin
Catalog No.:BCX1314
CAS No.:104196-69-2
- Rabdosia acid A
Catalog No.:BCX1315
CAS No.:1884697-13-5
Rhizobium rhizogenes infection in threatened Indian orchid Dendrobium ovatum mobilises 'Moscatilin' to enhance plant defensins.[Pubmed:35530740]
3 Biotech. 2022 May;12(5):119.
The present study illustrates the transformation ability of two wild-type bacterial strains of Rhizobium rhizogenes (MTCC 532 and MTCC 2364) on the embryogenic callus and callus-derived plantlets of a threatened Indian orchid, Dendrobium ovatum. Co-culture of the bacterium with the explants gave marginal hairy root phenotype that failed to multiply in the culture medium. Some primary and secondary metabolites were subdued in infected explants. Moscatilin, the stilbenoid active principle in D. ovatum, was found below the detection limit. The presence of two metabolites viz., Laudanosine, a benzyltetrahydroisoquinoline alkaloid and Lyciumin B, a cyclic peptide, were detected exclusively in the infected explants. The subjugated amino acids and phenolics in the infected plantlets were routed to produce phytoanticipins, and phenanthrenes, strengthening the defence mechanism in infected tissues. This research implies that the plant's defence mechanism activation could have prevented the extensive hairy root formation in the explants, even though nodulations and phenotype transitions were witnessed. Moscatilin has a structural resemblance with Resveratrol, a phytoalexin that combats bacterial and fungal pathogens. The study favours the possibility of Moscatlin being a precursor for phenanthrene compounds, thereby serving as a 'phytoanticipin' during the infection phase. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13205-022-03180-9.